Engineered MPXV A29 Protein (His Label): A Research Resource
Engineered MPXV A29 Protein (His Label): A Research Resource
Blog Article
This engineered MPXV A29L component, featuring a His tag, represents a valuable laboratory resource for study of Orthopoxvirus processes and possible medicinal areas. The His label facilitates for efficient separation and identification using conventional immobilized techniques, making it suitable for multiple applications including receptor interaction studies, Recombinant MPXV A29L Protein(His Tag) crystallization, and component synthesis studies. Ultimately, this produced protein provides a reproducible method to advance knowledge of Orthopoxvirus function.
Production and Characterization of Recombinant MPXV A29L Protein (His Tag)
The efficient production of recombinant MPXV A29L molecule, modified with a His tag, was achieved using *E. coli* production method. Initial procedures involved inserting the A29L DNA into a expression vector followed by transfection into competent *E. coli* cells. Following, optimized fermentation conditions were defined to boost production. Extraction of the His-tagged A29L protein was conducted utilizing immobilized metal affinity resin. Analysis involved approaches such as SDS-PAGE, Western blotting, and mass analysis to verify authenticity and evaluate estimated weight and clarity. The isolated recombinant A29L molecule exhibited appropriate mass and suggested the presence of the His label, validating successful production and purification.
Engineered Orthopoxvirus A29L Antigen (His Tag|with a His-tag|His-tagged) for Orthopoxvirus Investigations
The availability of engineered MPXV A29L antigen (His Tag) is a essential tool for advancing research into the biology of monkeypox infection. This molecule facilitates easy quantification and purification through His chromatography, permitting for detailed characterization of its functional properties, association with host factors, and role in viral replication. The His tag functions as a convenient handle for easy production and recovery, making it particularly suited for the range of monkeypox virus experiments.
Enhancing Production of Recombinant MPXV A29L Factor (His Tag | with a His Tag | tagged with His | featuring a His tag)
To achieve efficient yields of the expressed MPXV A29L factor , various parameters require meticulous optimization . Early attempts involved routine expression in *E. coli*, however, this often resulted in low output and marked inclusion structure formation. Consequently , methods such as altering the sequence strength, adjusting the culture environment , and employing aiding molecules to support proper conformation were utilized . Moreover , exploring other generation hosts , such as yeast , is being assessed to even boost production and improve compound performance.
Applications of Recombinant MPXV A29L Protein (His Tag) in Diagnostics
Recombinant MPXV A29L molecule (His marker) demonstrates crucial application in enhancing reliable identification methods for monkeypox virus. Its use as a antigen in immunoassays and lateral detection systems enables for specific binding of antibodies from affected individuals. The His label simplifies isolation and detection of the engineered A29L component, therefore increasing the total functionality and selectivity of the diagnostic process. Further investigation into its integration into multiplex identification systems persists a encouraging field of investigation.
Purified MPXV A29L Antigen (His Tag) Availability and Details
The engineered A29L protein from MPXV, featuring a His-affinity for easy isolation, is now accessible for laboratory use. This product is synthesized in Escherichia coli and provided as a freeze-dried form, allowing for extended keeping. Typical details include a molecular of approximately 140 kilodaltons, >90% purity as evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and a level of 1 mg/ml in a medium of PBS. Please the item guide for complete information regarding shipping conditions and suggested handling protocols.
Report this page